Pneumonia Clinical Trials in Tours
8 recruitingTours, France
Showing 1–8 of 8 trials
Recruiting
Phase 3
Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)
Community-acquired Pneumonia
Biotest590 enrolled147 locationsNCT05722938
Recruiting
Not Applicable
Immediate Versus Substantiated Antibiotic Therapy in Suspected Non-Severe Ventilator-Associated Pneumonia
Ventilator-Associated Pneumonia (VAP)
Nantes University Hospital686 enrolled41 locationsNCT06743529
Recruiting
Phase 2
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection
Viral Pneumonia
Synairgen Research Ltd.550 enrolled67 locationsNCT06999603
Recruiting
Phase 4
Clinical Trial Assessing the Immunogenicity of an Anti-pneumococcal Vaccination Strategy (PCV13+PPV23 Versus PREVENAR20) in Adult Patients Treated for a Lymphoma
Lymphoma, Non-HodgkinStreptococcus PneumoniaeVaccine
Poitiers University Hospital160 enrolled7 locationsNCT04460235
Recruiting
Long Term Effects of Awake Prone Positioning in COVID-19 ICU Patients
SARS-CoV 2 Pneumonia
University Hospital, Tours300 enrolled1 locationNCT06080737
Recruiting
Mucosal Associated Invariant T Cell During Viral Pneumonia and Acute Respiratory Distress Syndrome
Acute Respiratory Distress Syndrome (ARDS)Viral Pneumonia
University Hospital, Tours150 enrolled1 locationNCT06720818
Recruiting
Phase 1
Phase I Single-blind Clinical Trial to Evaluate the Safety and Local Immune Activation of a Toll-like Receptor 5 Agonist (FLAMOD) Administered by Aerosol
Pneumonia
Institut National de la Santé Et de la Recherche Médicale, France60 enrolled1 locationNCT06681402
Recruiting
Phase 3
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Community-acquired Pneumonia, Influenza, COVID-19
UMC Utrecht20,000 enrolled408 locationsNCT02735707